GBD 2015 Risk Factors Collaborators Global, regional, and national comparative risk assessment of 79 behavioral, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet 2016;388:1659-1724.

Singal AK, Bataller R, Ahn J, Kamath PS, Shah VH.ACG Clinical Guideline: Alcoholic Liver Disease. Am J Gastroenterol 2018:1-19.

Jürgen R, Gmel GE, Gmel G, Hasan OSM, Imtiaz S, Popova S, et al. The relationship between different dimensions of alcohol use and the burden of disease—an update. Addiction 2017:112:968-1001.

Yoon YH, Chen CM, Yi HY. Liver cirrhosis mortality in the United States: national, state, and regional trends, 2000–2011. Surveillance Report 2014:1-63.

Morgan TR, Mandayam S, Jamal MM. Alcohol and hepatocellular carcinoma. Gastroenterology 2004:127:87-96.

Saruta T, Ogihara T, Saito I, Rakugi H, Shimamoto K, Matsuoka H, et al. Comparison of olmesartan combined with a calcium channel blocker or a diuretic in elderly hypertensive patients (COLM Study): safety and tolerability.Hypertens Res 2015;38:132-136.

Runyon BA, AASLD. Introduction to the revised American Association for the Study of Liver Diseases Practice Guideline management of adult patients with ascites due to cirrhosis. Hepatology 2013;57:1651-1653.

European Association for the Study of the Liver. EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis. J Hepatol 2010;53: 397-417.

Tang JL, Liu BY, Ma KW. Traditional Chinese medicine.Lancet 2008;372:1938-1940.